Stem cell therapy is effective in spinal injuries treatment, says study

Image
IANS New Delhi
Last Updated : Jun 12 2016 | 7:57 PM IST

Stem-cell therapy can play a revolutionary role in the medical treatment of chronic spinal cord injuries, says an article published in 'Clinical and Translational Science' journal.

"Stem cell transplantation is a promising technology that has the potential to replace damaged neurons, re-establish lost axonal connections, and provide neuroprotective factors to allow for healing and recovery after Spinal Cord Injuries," wrote Geeta Shroff, medical director of New Delhi-based Nutech Mediworld, in the article.

According to the study, the evaluation to check the efficacy and safety of hESC (Human Embryonic Stem Cell) therapy was done after testing the therapy in 226 patients with spinal cord injuries.

Spinal cord injury (SCI) is a challenging neurological injury and is associated with permanent disability and decreased life expectancy.

"In our patients with SCI, hESC transplantation was safe and effective and helped improve their clinical condition. hESC therapy may present a significant advance in the treatment and rehabilitation of patients with SCI," said Shroff, a stem cell expert.

She said prospective controlled studies with control groups would give a better clarity on the use of hESC in patients with SCI.

A recent review of epidemiology of SCI in developing countries reported the incidence to be 25.5 million cases per year. In India, approximately 1.5 million people live with SCI and 10,000 new cases add to this group every year.

As part of the study, the data of a single cohort of patients with SCI treated with hESCs conducted during 24 May 2005 to 31 August 2012 at a single site in New Delhi, India, were collected retrospectively.

An independent ethics committee approved the study protocol.

--IANS

rup/kb/dg

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 12 2016 | 7:46 PM IST

Next Story